Latest Capital Raise News

Sunshine Metals has reported standout drilling results from its Liontown Gold Panel, including 22 metres at 20.25 grams per tonne gold, underpinning a resource update and revised mining study planned for mid-2026.

FirstWave Cloud Technology delivered a strong Q3 FY26 with a $1.40m net operating cash inflow and a major two-year licensing agreement with Mexico’s Banobras bank, marking a key milestone in its AI compliance pivot.

European Resources Limited has closed a renounceable rights issue raising $2.57 million before costs, issuing 171.4 million new shares and options to fuel exploration and metallurgical programs in Finland and Slovakia.

Hawk Resources has locked in $5.87 million through a placement and entitlement offer, backing its push into scandium exploration in Western Australia and copper drilling in the US.

Neurizon Therapeutics has gained ethics approval to start a Phase 1 trial of its NUZ-001 oral liquid formulation, aiming to ease treatment for ALS patients with swallowing difficulties.

Regener8 Resources has formalised its acquisition of the Srebrenica North polymetallic project in Bosnia and Herzegovina, setting the stage for a maiden exploration program targeting high-grade silver and base metals in a prolific European mining district.

Conico Ltd has applied for two extensive exploration licences in East Greenland targeting rare earth elements and gold-PGE mineralisation, significantly boosting its strategic landholding and critical minerals exposure.

Paladin Energy Ltd (ASX:PDN) swung to a quarterly profit with US$8.4 million gross profit and bolstered its balance sheet through a A$400 million equity raise, positioning itself for expansion in uranium production and development.

Elevra Lithium has raised A$275 million through a fully underwritten institutional placement to fund its North American Lithium expansion and Moblan project development, supported by strong institutional demand.

Terrain Minerals has launched a substantial induced polarisation survey at its Smokebush Gold Project, aiming to identify new gold-bearing structures akin to the Lightning discovery within untested ground. Results are due alongside a maiden resource estimate in July 2026.

Anteris Technologies reported a $22.9 million net loss in Q1 2026 but bolstered its cash position to $283 million following a $320 million capital raise. The company is scaling manufacturing and clinical activities for its DurAVR transcatheter heart valve, with US patient enrolment now underway in the pivotal PARADIGM Trial.

5E Advanced Materials secures a decade-long boric acid offtake agreement and advances boron product development, while reporting a $12.1 million quarterly loss and planning ASX delisting.